Searchable abstracts of presentations at key conferences in endocrinology

ea0022p565 | Neuroendocrinology and Pituitary (<emphasis role="italic">Generously supported by Novartis</emphasis>) | ECE2010

Daily temozolomide therapy in Nelson's syndrome

Ortiga Ruth Sanchez , Sanchez Victor L Gonzalez , Perez Oscar Moreno , Meana Andres , Alfonso Antonio A Pico

Temozolomide, an alkylating agent used in malignant gliomas, has been recently used too in the treatment of aggressive pituitary tumors. To date, two cases of Nelson’s syndrome has successfully treated with 5 days of 28-day cycle, but the follow-up has been shorter than 12 months. We reported the third patient with Nelson’s syndrome treated with temozolomide, who after an initial goal response to three 300 mg 5 days of 28-day cycles shown a clinical and biochemical (...

ea0022p597 | Neuroendocrinology and Pituitary (<emphasis role="italic">Generously supported by Novartis</emphasis>) | ECE2010

Contribution of the molecular biology to the study of the behaviour of pituitary adenomas

Sanchez-Tejada Laura , Sanchez-Ortiga Ruth , Niveiro Maria , Peiro Gloria , Moreno Oscar , Aranda Ignacio , Alfonso Antonio A Pico

Background: There is an increasing interest to find specific prognostic markers of the aggressive behaviour of some pituitary adenomas (PA). The most studied markers have been the immunohistochemical staining for Ki-67 and p53. The aim of this study was to evaluate the relevance as possible prognostic markers of growth factors (IGF1R), angiogenic factors (VEGF and his receptor) and new genes (PTTG) versus the immunohistochemical expression of Ki-67 and p53 in PA.<p class="...

ea0022p532 | Male reproduction | ECE2010

Validation of salivary testosterone as a diagnostic test in the hypothalamic–pituitary–gonadal axis diseases

Moreno-Perez Oscar , Gonzalez-Sanchez Victor Luis , Romualdo Luis Garcia de Guadiana , Sanchez-Ortiga Ruth , Guerra Rocio Alfayate , Dot Monserrat Mauri , Alfonso Antonio Miguel Pico

Introduction: Salivary testosterone (Sal-T) reflects the plasma free testosterone fraction that can flow passively through the salivary glands and appears to be a strong correlation with the Calculated free testosterone (CFT) in both eugonadal and hypogonadal men. Since the collection of saliva is simple, noninvasive and inexpensive, the Sal-T is a promising tool for the screening of hypogonadism. Despite the initial interest that Sal-T has aroused, new clinical studies are ne...

ea0022p533 | Male reproduction | ECE2010

Determination of the reference values of total testosterone, calculated free testosterone, calculated bioavailable testosterone and salivary testosterone in young, healthy population of the Mediterranean area

Gonzalez-Sanchez Victor Luis , Moreno-Perez Oscar , Romualdo Luis Garcia de Guadiana , Pellicer Pedro Sanchez , Dot Monserrat Mauri , Paya Jose Sanchez , Alfonso Antonio Miguel Pico

Introduction: Free testosterone (FT) and bioavailable testosterone (BT), are better surrogate markers of the androgenic status of the individual than total testosterone (TT). Calculated FT (CFT) and calculated BT (CBT) which take into consideration the kinetics of the bond between FT and albumin and SHBG, provide results practically identical to those of the reference techniques. Salivary testosterone (Sal-T) is a promising tool in the study of gonadal pathology. The interassa...

ea0022p602 | Neuroendocrinology and Pituitary (<emphasis role="italic">Generously supported by Novartis</emphasis>) | ECE2010

Application of the human chorionic gonadotropin immunoassay in cerebrospinal fluid for the diagnostic work-up of neurohypophyseal germinomas

Gonzalez-Sanchez Victor Luis , Moreno-Perez Oscar , Pellicer Pedro Sanchez , Sanchez-Ortiga Ruth , Dot Monserrat Mauri , Simeon Elena Gastaldo , Lopez Ignacio Aranda , Alfonso Antonio Miguel Pico

Context: The determination of human chorionic gonadotropin (hCG) in cerebrospinal fluid (CSF) is useful for the differential diagnosis of suprasellar lesions. However, the concentrations that prove diagnostic for neurohypophyseal germinoma have not been well defined. In addition, the immunoassays used for such determination are the same as those applied in serum, and few studies have been performed regarding the validation of such techniques in CSF.Objec...

ea0037ep789 | Pituitary: clinical | ECE2015

Acrostart: Spanish retrospective study to determine the timeframe to achieve hormonal normalisation with initial Somatuline Autogel® treatment in acromegaly patients in routine clinical practice

Escola Cristina Alvarez , Moreno Eva Maria Venegas , Arnes Juan Antonio Garcia , Carrera Concepcion Blanco , Azpiroz Monica Marazuela , Moreno Maria Angeles Galvez , Torre Edelmiro Menendez , Pardo Javier Aller , Vert Isabel Salinas , Resmini Eugenia , Vela Elena Maria Torres , Redondo Maria Angeles Gonzalo , Joya Ricardo Vilchez , Novoa Maria Paz de Miguel , Rabinovich Irene Halperin , Fernandez Concepcion Paramo , Alfonso Antonio Miguel Pico , Arroyo Sara , Perez Francesc , Pineda Eva

Introduction: This study aimed to determine the timeframe to achieve hormonal normalization considering dosing patterns of Somatuline Autogel (SOM, lanreotide) used in clinical practice.Methods: From March 2013 to October 2013 clinical data from 62 patients with active acromegaly treated with SOM for &gE;4 months who achieved hormonal control (GH levels <2.5 ng/ml and/or normalised IGF1 on &gE;two evaluations) at 17 Spanish hospitals were collected i...